DE60138321D1 - Verfahren zur Identifizierung während der Apoptose modifizierter Proteine - Google Patents

Verfahren zur Identifizierung während der Apoptose modifizierter Proteine

Info

Publication number
DE60138321D1
DE60138321D1 DE60138321T DE60138321T DE60138321D1 DE 60138321 D1 DE60138321 D1 DE 60138321D1 DE 60138321 T DE60138321 T DE 60138321T DE 60138321 T DE60138321 T DE 60138321T DE 60138321 D1 DE60138321 D1 DE 60138321D1
Authority
DE
Germany
Prior art keywords
modified proteins
during apoptosis
identifying during
identifying
apoptosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60138321T
Other languages
English (en)
Inventor
Thomas Dr Rudel
Bernd Dr Thiede
Nikolaus Machuy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP00112813A external-priority patent/EP1164374A1/de
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60138321D1 publication Critical patent/DE60138321D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/561—Immunoelectrophoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2550/00—Electrophoretic profiling, e.g. for proteome analysis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60138321T 2000-06-16 2001-06-15 Verfahren zur Identifizierung während der Apoptose modifizierter Proteine Expired - Lifetime DE60138321D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00112813A EP1164374A1 (de) 2000-06-16 2000-06-16 Verfahren zur Identifizierung während der Apoptose modifizierter Proteine
EP00125013 2000-11-16

Publications (1)

Publication Number Publication Date
DE60138321D1 true DE60138321D1 (de) 2009-05-20

Family

ID=26071055

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60138321T Expired - Lifetime DE60138321D1 (de) 2000-06-16 2001-06-15 Verfahren zur Identifizierung während der Apoptose modifizierter Proteine

Country Status (6)

Country Link
US (1) US20040022779A1 (de)
EP (2) EP1290446A2 (de)
AT (1) ATE428116T1 (de)
AU (1) AU2001266070A1 (de)
DE (1) DE60138321D1 (de)
WO (1) WO2001096873A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060199946A1 (en) 2003-04-21 2006-09-07 Hideaki Shimada Apoptosis inducing agent and method for inducing apoptosis
DE102010048899B8 (de) * 2010-10-19 2012-06-14 Universitätsklinikum Schleswig-Holstein Campus Lübeck Verfahren zum Diagnostizieren aneuploider kolorektaler Tumore
WO2013192298A1 (en) * 2012-06-22 2013-12-27 The Scripps Research Institute Apoptosis biomarkers
PE20160122A1 (es) 2013-03-13 2016-02-12 Forma Therapeutics Inc Compuestos nobles y composiciones para la inhibicion de fasn
EP3375450B1 (de) * 2015-11-13 2023-06-28 Industry - University Cooperation Foundation Hanyang University Zusammensetzung zur behandlung oder vorbeugung von einer ischämischen zerebrovaskulären erkrankung über nasale verabreichung
US11434468B2 (en) * 2017-01-13 2022-09-06 Bened Biomedical Co., Ltd. Lactic acid bacteria and its applications
TWI767148B (zh) 2018-10-10 2022-06-11 美商弗瑪治療公司 抑制脂肪酸合成酶(fasn)
CN113382633A (zh) 2018-10-29 2021-09-10 福马治疗股份有限公司 (4-(2-氟-4-(1-甲基-1H-苯并[d]咪唑-5-基)苯甲酰基)哌嗪-1-基)(1-羟基环丙基)甲酮的固体形式

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL116026A (en) * 1994-11-22 2005-08-31 Rhone Poulenc Rorer Sa Peptides capable of linking to the sh3 domain of gap, nucleotide sequences encoding the same, their preparation and uses
US6156535A (en) * 1995-08-04 2000-12-05 University Of Ottawa Mammalian IAP gene family, primers, probes, and detection methods
EP0924296A3 (de) * 1997-12-03 2001-08-01 Leadd B.V. Verfahren un Mittteln für die Induktion von Apoptosis durch Interferenz in RNS-Prozessierung
EP1080233A4 (de) * 1998-05-18 2003-02-05 Apoptosis Technology Inc Verbindungen, untersuchungsverfahren und verwendungen die anti-apoptotische gene und genprodukte beinhalten
FR2780062B1 (fr) * 1998-06-17 2000-07-28 Rhone Poulenc Rorer Sa Anticorps monoclonaux diriges contre la proteine g3bp, et leurs utilisations

Also Published As

Publication number Publication date
US20040022779A1 (en) 2004-02-05
EP1764616A2 (de) 2007-03-21
AU2001266070A1 (en) 2001-12-24
WO2001096873A3 (en) 2002-04-25
WO2001096873A2 (en) 2001-12-20
EP1764616B1 (de) 2009-04-08
ATE428116T1 (de) 2009-04-15
EP1764616A3 (de) 2007-03-28
EP1290446A2 (de) 2003-03-12

Similar Documents

Publication Publication Date Title
DE60212193D1 (de) Verfahren zur verbesserung der reproduktionsleistung bei geflügel
ATE388132T1 (de) Verfahren zur hydroformylierung von olefinen
ATE335511T1 (de) Ein verfahren zur inhibierung der komplementaktivierung über einen alternativen weg
ATE250066T1 (de) Verfahren zur reduktion von oxiranyl-epothilonen zu olefinischen epothilonen
DE69817839D1 (de) Verfahren zur erhöhung der photosynthese
DE60237184D1 (de) Verfahren zur Erzeugung von Bewegungen
DE59902020D1 (de) Verfahren zur Hydrierung von Hydroformylierungsgemischen
DE59904157D1 (de) Verfahren zur hydrierung von carbonylverbindungen
DE50011437D1 (de) Verfahren zur Erzeugung von Justiermarken
DE60139614D1 (de) Verfahren zur s.i.p/h.323-zusammenarbeit
DE59800221D1 (de) Verfahren zur Stabilisierung von Retinol bzw. Retinol-Derivaten
DE69904754D1 (de) Verfahren zur bioanalyse
ATE244231T1 (de) Verfahren zur epoxidierung von olefinen
ATE376289T1 (de) Verfahren zur signalisierung von konfigurationsparametern physikalischer kanäle
DE60008075D1 (de) Verfahren zur übermittlung von information
DE50109692D1 (de) Verfahren zur beurteilung des verschleisses von motoröl
DE60124884D1 (de) Verfahren zur verbesserung der fotomaskengeometrie
ATE316955T1 (de) Verfahren zur hydrocyanierung von äthylenisch ungesättigten organischen verbindungen
DE60018902D1 (de) Verfahren zur herstellung von nitroxymethylphenylestern von aspirinderivaten
DE60138321D1 (de) Verfahren zur Identifizierung während der Apoptose modifizierter Proteine
DE60104203D1 (de) Verfahren zur Übertragung von Signalisierungsinformationen über zwei Kanälen
DE60024403D1 (de) Verfahren zur extraktion von klangquellen-informationen
ATE378307T1 (de) Verfahren zur gewinnung von cetamin-enantiomeren.
DE60032077D1 (de) Verfahren zur dehalogenierung von kohlenwasserstoffhaltigen kohlenstoff-kohlenstoff doppelbindungen
ATE297909T1 (de) Verfahren zur epoxidierung von olefinen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1764616

Country of ref document: EP

Representative=s name: WEICKMANN & WEICKMANN, 81679 MUENCHEN, DE